Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2025-12-24 @ 3:57 PM
NCT ID:
NCT06670092
Eligibility Criteria:
Inclusion Criteria:
1. Have a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) of the combined or hyperkinetic type.
2. Be between 6 and 12 years of age.
3. Be under treatment with methylphenidate.
4. IQ of 100 or higher.
5. Have a normal neurological examination.
6. Not dysmorphic.
7. Not have received specific physiotherapy treatment for the improvement of balance and postural control in the two months prior to inclusion in the study.
Exclusion Criteria:
1. Present a diagnosis of ADHD comorbid with other neuropsychiatric pathologies.
2. Have a history of neurological or musculoskeletal disorders that are linked to a deficit in balance and/or postural control.
3. Be under treatment with atomoxetine.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
12 Years
Study:
NCT06670092
Study Brief:
Protocol Section:
NCT06670092